Asunto(s)
Adhesión a Directriz , Conocimientos, Actitudes y Práctica en Salud , Personal de Salud/estadística & datos numéricos , Unidades Hospitalarias/estadística & datos numéricos , Vacuna contra la Tos Ferina/administración & dosificación , Vacunación/estadística & datos numéricos , Tos Ferina/prevención & control , Adulto , Femenino , Francia/epidemiología , Encuestas Epidemiológicas , Humanos , Inmunización Secundaria/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Encuestas y CuestionariosRESUMEN
Phaeochromocytoma and paraganglioma are chromaffine tumours secreting catecholamines. They are usually revealed by a paroxystic hypertensive crisis associated with headaches, palpitation and sweats. We reported a case of a young patient presenting a state of life threatening cardiogenic shock as unusual revelation of this tumour, requiring the implementation of an extracorporeal life support until myocardial recovery.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/complicaciones , Neoplasias de las Glándulas Suprarrenales/metabolismo , Circulación Asistida , Catecolaminas/metabolismo , Paraganglios Cromafines/metabolismo , Paraganglioma/complicaciones , Choque Cardiogénico/terapia , Adolescente , Neoplasias de las Glándulas Suprarrenales/cirugía , Antagonistas de Dopamina , Electrocardiografía , Femenino , Hemodinámica/fisiología , Humanos , Complicaciones Intraoperatorias/diagnóstico por imagen , Complicaciones Intraoperatorias/terapia , Metoclopramida , Paraganglioma/metabolismo , Paraganglioma/cirugía , Feocromocitoma/complicaciones , Choque Cardiogénico/diagnóstico por imagen , Choque Cardiogénico/etiología , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
Glycogenosis type II (GSD II) is a lysosomal disorder affecting skeletal and cardiac muscle. In the infantile form of the disease, patients display cardiac impairment, which is fatal before 2 years of life. Patients with juvenile or adult forms can present diaphragm involvement leading to respiratory failure. The enzymatic defect in GSD II results from mutations in the acid alpha-glucosidase (GAA) gene, which encodes a 76 kDa protein involved in intralysosomal glycogen hydrolysis. We previously reported the use of an adenovirus vector expressing GAA (AdGAA) for the transduction of myoblasts and myotubes cultures from GSD II patients. Transduced cells secreted GAA in the medium, and GAA was internalized by receptor-mediated capture, allowing glycogen hydrolysis in untransduced cells. In this study, using a GSD II mouse model, we evaluated the feasibility of GSD II gene therapy using muscle as a secretary organ. Adenovirus vector encoding AdGAA was injected in the gastrocnemius of neonates. We detected a strong expression of GAA in the injected muscle, secretion into plasma, and uptake by peripheral skeletal muscle and the heart. Moreover, glycogen content was decreased in these tissues. Electron microscopy demonstrated the disappearance of destruction foci, normally present in untreated mice. We thus demonstrate for the first time that muscle can be considered as a safe and easily accessible organ for GSD II gene therapy.
Asunto(s)
Terapia Genética/métodos , Glucano 1,4-alfa-Glucosidasa/genética , Glucano 1,4-alfa-Glucosidasa/metabolismo , Enfermedad del Almacenamiento de Glucógeno Tipo II/genética , Enfermedad del Almacenamiento de Glucógeno Tipo II/terapia , Músculo Esquelético/metabolismo , Adenoviridae/genética , Animales , Vectores Genéticos/farmacología , Glucógeno/metabolismo , Inyecciones Intramusculares , Lisosomas/efectos de los fármacos , Lisosomas/metabolismo , Ratones , Ratones Noqueados , Microscopía Electrónica , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , alfa-GlucosidasasRESUMEN
A new indirect method for measuring the level of beta-methyl-gamma-octalactone precursors in oak wood by GC-MS is described. This level is calculated from the difference between the amount of free beta-methyl-gamma-octalactone and the amount formed after hydrolysis and lactonization. It is compared to the level of a precursor of cis-beta-methyl-gamma-octalactone, a 6'-O-gallate derivative of (3S,4S)-4-[3-beta-glucopyranosyloxy-3-methyloctanoic acid, determined directly by HPLC. These two methods are applied to 12 powdered samples of Sessile oak wood and the results show that the 6'-O-gallate derivative of (3S,4S)-4-beta-D-glucopyranosyloxy-3-methyloctanoic acid is by far the most abundant precursor of beta-methyl-gamma-octalactone in this wood.
Asunto(s)
4-Butirolactona/análisis , Árboles/química , 4-Butirolactona/análogos & derivados , Cromatografía de Gases y Espectrometría de Masas/métodos , Estándares de ReferenciaRESUMEN
OBJECTIVE: To characterize the phenotypes of patients with juvenile and adult-onset acid maltase deficiency (AMD) in the French population and correlate them with genetic defects. BACKGROUND: AMD is an autosomal recessive disorder caused by the absence of the enzyme acid a-glucosidase (GAA). Patients are generally compound heterozygotes for various mutations in the GAA gene. The most common mutant allele is a -13T to G transversion in intron 1. METHODS: The authors performed a clinical, biochemical, and genetic study on 21 unrelated patients with juvenile and adult-onset AMD. RESULTS: Although onset of progressive muscle weakness occurred during adulthood in all cases but one, presence of mild, nonprogressive muscular symptoms appearing during childhood was detected in 16 patients. Eighteen patients had a similar clinical pattern with pelvic girdle muscle weakness predominating in glutei and thigh adductors. Restrictive respiratory insufficiency with vital capacity less than 60% was noted in eight patients, and respiratory failure was the first manifestation in two cases. All patients but one were compound heterozygotes, and 17 carried the IVS1 (-13T ---> G) transversion (one patient was homozygous for this mutation). The two mutated alleles were identified in 10 cases, with 13 different mutations detected in the GAA gene. There was no clear correlation between the type of mutation and phenotype. CONCLUSIONS: This study shows a high genetic heterogeneity of juvenile and adult AMD in the French population. The absence of genotype-phenotype correlation suggests a complex physiopathology that requires further investigations.
Asunto(s)
Enfermedad del Almacenamiento de Glucógeno Tipo II/genética , Adolescente , Adulto , Edad de Inicio , Anciano , Niño , Femenino , Francia , Genotipo , Enfermedad del Almacenamiento de Glucógeno Tipo II/patología , Humanos , Masculino , Persona de Mediana Edad , Músculos/diagnóstico por imagen , Músculos/patología , Mutación/genética , Fenotipo , Tomografía Computarizada por Rayos XRESUMEN
The 6'-O-gallate derivative of (3S, 4S)-4-beta-D-glucopyranosyloxy-3-methyloctanoic acid was isolated for the first time from the wood of Sessile oak (Quercus petraea (Matt.) Liebl.) and shown to be a precursor of cis-beta-methyl-gamma-octalactone. The structure of this precursor was determined by HRFAB-MS, NMR, LCMS, and chiral analysis of the liberated (3S,4S)-beta-methyl-gamma-octalactone on a chiral fused silica capillary column. Optical rotation was shown to be identical to that of the same compound previously isolated from the wood of Platycarya strobilacea Sieb. et Zucc. by Tanaka and Kouno in 1996. Moreover, the 6'-O-gallate derivative of a threo-4-beta-D-glucopyranosyloxy-3-methyloctanoic acid was tentatively identified as a minor precursor of trans-beta-methyl-gamma-octalactone in the same wood of Sessile oak.
Asunto(s)
Lactonas/química , Árboles/química , MaderaRESUMEN
Brandies, cognac, armagnac, whiskeys, and rums are aged in oak barrels to improve their organoleptic properties. During this period, numerous compounds such as ellagitannins are extracted from the wood and can subsequently be transformed into new derivatives by chemical reactions. Model solutions of castalagin and vescalagin have been studied to determine the behavior of polyphenols in ethanol-water. Upon prolonged exposure to 40 and 70% (v/v) ethanol at room temperature, hemiketal derivatives containing ethoxy groups have been characterized by LC/MS and NMR. These compounds further evolve to afford the corresponding ketals. They have also been detected in the extracts of oak wood stored under similar conditions.
Asunto(s)
Bebidas Alcohólicas , Compuestos de Bifenilo , Catecoles/química , Taninos Hidrolizables , Antihipertensivos/química , Cromatografía Líquida de Alta Presión , Etanol , Manipulación de Alimentos , Conformación Molecular , Estructura Molecular , Soluciones , Taninos/química , Taninos/aislamiento & purificación , MaderaRESUMEN
Glycogen storage disease type II (GSD II) is an autosomal recessive disorder caused by defects in the lysosomal acid alpha-glucosidase (GAA) gene. We investigated the feasibility of using a recombinant adenovirus containing the human GAA gene under the control of the cytomegalovirus promoter (AdCMV-GAA) to correct the enzyme deficiency in different cultured cells from patients with the infantile form of GSD II. In GAA-deficient fibroblasts infected with AdCMV-GAA, transduction and transcription of the human transgene resulted in de novo synthesis of GAA protein. The GAA enzyme activity was corrected from the deficient level to 12 times the activity of normal cells. The transduced cells overexpressed the 110 kDa precursor form of GAA, which was secreted into the culture medium and was taken up by recipient cells. The recombinant GAA protein was correctly processed and was active on both an artificial substrate 4-methylumbelliferyl-alpha-D-glucopyranoside (4MUG) and glycogen. In GAA-deficient muscle cells, a significant increase in cellular enzyme level, approximately 20-fold higher than in normal cells, was also observed after viral treatment. The transduced muscle cells were also able to efficiently secrete the recombinant GAA. Moreover, transfer of the human transgene resulted in normalization of cellular glycogen content with clearance of glycogen from lysosomes, as assessed by electron microscopy, in differentiated myotubes. These results demonstrate phenotypic correction of cultured skeletal muscle from a patient with infantile-onset GSD II using a recombinant adenovirus. We conclude that adenovirus-mediated gene transfer might be a suitable model system for further in vivo studies on delivering GAA to GSD II muscle, not only by direct cell targeting but also by a combination of secretion and uptake mechanisms.
Asunto(s)
Adenoviridae/genética , Técnicas de Transferencia de Gen , Enfermedad del Almacenamiento de Glucógeno Tipo II/terapia , alfa-Glucosidasas/genética , alfa-Glucosidasas/metabolismo , Western Blotting , Células Cultivadas , Fibroblastos/metabolismo , Terapia Genética/métodos , Glucógeno/metabolismo , Enfermedad del Almacenamiento de Glucógeno Tipo II/genética , Humanos , Músculo Esquelético/citología , Músculo Esquelético/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacocinética , Transducción Genética , alfa-Glucosidasas/farmacocinéticaRESUMEN
Gaucher disease (GD) is one of the most prevalent lysosomal storage disorders and one of the rare genetic diseases now accessible to therapy. Outside the Ashkenazi Jewish community, a high molecular diversity is observed, leaving approximately 30% of alleles undetected. Nevertheless, very few exhaustive methods have been developed for extensive gene screening of a large series of patients. Our approach for a complete search of mutations was the association of fluorescent chemical cleavage of mismatches with a universal strand-specific labeling system. The glucocerebrosidase (GBA) gene was scanned by use of a set of six amplicons, comprising 11 exons, all exon/intron boundaries, and the promoter region. By use of this screening strategy, the difficulties due to the existence of a highly homologous pseudogene were easily overcome, and both GD mutant alleles were identified in all 25 patients studied, thus attesting to a sensitivity that approaches 100%. A total of 18 different mutations and a new glucocerebrosidase haplotype were detected. The mutational spectrum included eight novel acid beta-glucosidase mutations: IVS2 G(+1)-->T, I119T, R170P, N188K, S237P, K303I, L324P, and A446P. These data further indicate the genetic heterogeneity of the lesions causing GD. Established genotype/phenotype correlations generally were confirmed, but notable disparities were disclosed in several cases, thus underlining the limitation in the prognostic value of genotyping. The observed influence of multifactorial control on this monogenic disease is discussed.
Asunto(s)
Enfermedad de Gaucher/enzimología , Enfermedad de Gaucher/genética , Glucosilceramidasa/genética , Mutación Missense , Mutación Puntual , beta-Glucosidasa/genética , Adolescente , Adulto , Anciano , Emparejamiento Base , Niño , Preescolar , Cartilla de ADN , Exones , Femenino , Variación Genética , Humanos , Intrones , Judíos/genética , Masculino , Persona de Mediana Edad , Paris , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Regiones Promotoras Genéticas , Seudogenes , beta-Glucosidasa/químicaRESUMEN
The action of an inhibitor on a stationary enzyme reaction is described by a simple equation, which reflects how the progressive binding of inhibitor molecules influences the existence and the productivity of the enzyme forms. This allows deduction of the structure of the enzyme system from the experimental results, using new type of plots (1/[I], 1/[I](a)v) where a = 0,1,2,... in complement to the usual graphs. A reaction scheme is thereby logically built. This method may be used without any theoretical calculation. It is valid whatever the inhibitor, when the association reactions of the substrates and the inhibitor to the enzyme are in rapid equilibrium, and with dead end inhibitors, more generally for steady state enzyme reactions. This method may be adapted to enzyme activation. An original inhibition mode is described with particular bifunctional molecules: cooperative binding of the inhibitor to the enzyme, outside the active site, by direct mutual interaction of two inhibitor molecules, and locking of the conformational changes that normally precede the release of the products.
Asunto(s)
Inhibidores Enzimáticos/química , Fosfoglicerato Quinasa/antagonistas & inhibidores , Trypanosoma brucei brucei/enzimología , Animales , Sitios de Unión , Inhibidores Enzimáticos/farmacología , Cinética , Matemática , Estructura Molecular , Ácidos Ftálicos/química , Ácidos Ftálicos/farmacología , Unión Proteica , Suramina/farmacologíaRESUMEN
Glycogen-storage disease type II (GSD II, acid maltase deficiency, Pompe's disease) is caused by defects in the lysosomal acid alpha-glucosidase (GAA) gene. Clinically, patients with the severe infantile form of GSD II have muscle weakness and cardiomyopathy eventually leading to death before the age of two years. Patients with the juvenile or the adult form of GSD II present with myopathy with a slow progression over several years or decades. Apart from a common base substitution in intron1, designated IVS1(-13T-->G) and resulting in the aberrant splicing of exon 2, the other mutations recently discovered in the GAA gene are rare and often unique to single patients. In this paper, we identified a two-base frameshift deletion in three unrelated adult-onset GSD II patients. This small deletion lies in the first coding exon (exon 2) and results in a premature stop codon at the very 5' end of the coding sequence of the GAA gene. The three patients were compound heterozygotes and two of them had the common IVS1(-13G-->T) mutation on the second allele. We speculate that this novel deletion may be relatively frequent among French patients, possibly leading to the severe infantile phenotype of GSD II if it occurs in homozygous form.
Asunto(s)
Glucano 1,4-alfa-Glucosidasa/genética , Enfermedad del Almacenamiento de Glucógeno Tipo II/genética , Eliminación de Secuencia/genética , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Codón de Terminación , Femenino , Mutación del Sistema de Lectura , Francia , Glucano 1,4-alfa-Glucosidasa/química , Glucano 1,4-alfa-Glucosidasa/deficiencia , Enfermedad del Almacenamiento de Glucógeno Tipo II/enzimología , Heterocigoto , Humanos , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Análisis de Secuencia , alfa-GlucosidasasRESUMEN
Tay-Sachs disease is an autosomal recessive lysosomal storage disease caused by beta-hexosaminidase A deficiency and leads to death in early childhood. The disease results from mutations in the HEXA gene, which codes for the alpha chain of beta-hexosaminidase. The castastrophic neurodegenerative progression of the disease is thought to be a consequence of massive neuronal accumulation of GM2 ganglioside and related glycolipids in the brain and nervous system of the patients. Fuller understanding of the pathogenesis and the development of therapeutic procedures have both suffered from the lack of an animal model. We have used gene targeting in embryonic stem (ES) cells to disrupt the mouse Hexa gene. Mice homozygous for the disrupted allele mimic several biochemical and histological features of human Tay-Sachs disease. Hexa-/- mice displayed a total deficiency of beta-hexosaminidase A activity, and membranous cytoplasmic inclusions typical of GM2 gangliosidoses were found in the cytoplasm of their neurons. However, while the number of storage neurons increased with age, it remained low compared with that found in human, and no apparent motor or behavioral disorders could be observed. This suggests that the presence of beta-hexosaminidase A is not an absolute requirement of ganglioside degradation in mice. These mice should help us to understand several aspects of the disease as well as the physiological functions of hexosaminidase in mice. They should also provide a valuable animal model in which to test new forms of therapy, and in particular gene delivery into the central nervous system.
Asunto(s)
Enfermedades por Almacenamiento Lisosomal/genética , beta-N-Acetilhexosaminidasas/genética , Animales , Secuencia de Bases , Encéfalo/metabolismo , Encéfalo/patología , Línea Celular , Cartilla de ADN , Femenino , Hexosaminidasa A , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Neuronas/metabolismo , Fenotipo , ARN/genética , Reproducción , Enfermedad de Tay-Sachs/genética , beta-N-Acetilhexosaminidasas/deficiencia , beta-N-Acetilhexosaminidasas/metabolismoRESUMEN
There are close links between bone metabolism and bone circulation. Osteoblasts are derived from the walls of the venous sinuses. As shown by Burkardt, osteoporosis is accompanied by a decrease in the number of intra-osseous capillaries, and intra-osseous arterioles may be the site of arteriosclerosis lesions. In order to determine the existence of a possible link between arteriosclerosis and male osteoporosis, the etiology of which is often poorly defined, the authors studied phosphorus-calcium balance, X-rays of the spine, and bone density of the spine and the femoral neck in 17 male arterial disease sufferers with a mean age of 61 and at Leriche stage 2, 3 or 4. These 17 patients were compared with 15 age-paired controls. Wedge fractures, absent in the control group, were seen in 9 of the 17 patients. Bone mineral content in the femoral neck was significantly reduced in the arterial disease group.
Asunto(s)
Arteriosclerosis/complicaciones , Calcio/análisis , Pierna/irrigación sanguínea , Osteoporosis/complicaciones , Arteriosclerosis/diagnóstico por imagen , Arteriosclerosis/epidemiología , Arteriosclerosis/metabolismo , Circulación Sanguínea , Densidad Ósea , Huesos/irrigación sanguínea , Calcio/metabolismo , Cuello Femoral/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Osteoporosis/epidemiología , Fósforo/análisis , Fósforo/metabolismo , Estudios Prospectivos , Radiografía , Factores Sexuales , Columna Vertebral/diagnóstico por imagen , Columna Vertebral/metabolismoRESUMEN
A method is described for determination of ellagitannins in ethanol-water extracts of oak wood and in distilled alcoholic beverages matured in oak barrels. It is based on the combined ellagic acid content according to ellagitannin structure. Hydrolysis was carried out in the presence of hydrochloric acid under reflux in a 100 degrees C oil bath for 3 h. Total ellagic acid was thus determined by liquid chromatography (LC), and the free ellagic acid content present in the ethanol-water media was subtracted, the difference being the combined ellagic acid content corresponding to ellagitannins. A 5 micron C18 column was used with detection at 254 nm. The method is specific for ellagitannins, which is an advantage over other analytical techniques for overall evaluation of these substances extracted from wood. Results for spirits distilled from wine, grain, and sugarcane were highly variable.
Asunto(s)
Bebidas Alcohólicas/análisis , Taninos/análisis , Madera , Cromatografía Liquida , Ácido Elágico/análisis , Hidrólisis , Indicadores y ReactivosRESUMEN
Human pancreatic cells of the Capan-1 line form domes in culture during the stationary growth stage. The domes are thought to be a result of the transport of water and electrolytes by the Capan-1 cells. In older Capan-1 cultures, the epithelial sheets formed thickenings from several layers of cells of which the outermost ones were joined by tight type junctions. In the intracellular space, deposits of insoluble calcium salts were observed. Culture of Capan-1 cells in the presence of fibroblasts prolonged survival of the cultures with intact domes for more than 80 days. The Capan-1 cells proliferated forming multilayers and closed cavities which we called super-domes. X-ray spectrometry and electron diffraction analysis showed that the abundant deposits inside these cavities consisted of calcium phosphate in an apatite structure. The number of these deposits increased with time in culture, and they appeared to be formed at the sites of contact with an extracellular matrix consisting of cell debris. Deposits were not observed within the culture medium. Cells from domes were stained cytochemically for ATPases and alkaline phosphatases and examined by light and electron microscopy. The Capan-1 cells surrounding the domes were differentiated, polarized cells containing placental type alkaline phosphatases on their apical membranes and Ca2(+)-ATPases on their basolateral membranes. These enzymes were thought to play a role in the accumulation of phosphate and Ca2+ ions in the dome cavities, which then formed crystals in the presence of organic compounds produced by lysis of cells of the deepest layers of the super-domes. The crystals of hydroxyapatite observed in standard Capan-1 cell cultures and those cocultured with fibroblasts were assumed to be a result of transepithelial transport of Ca2+ and phosphate ions by these cells.
Asunto(s)
Adenocarcinoma/patología , Fosfatos de Calcio/análisis , Neoplasias Pancreáticas/patología , Adenocarcinoma/química , Adenocarcinoma/metabolismo , Fosfatasa Alcalina/análisis , Transporte Biológico Activo , ATPasas Transportadoras de Calcio/análisis , División Celular , Cristalización , Durapatita , Humanos , Hidroxiapatitas/análisis , Neoplasias Hepáticas/metabolismo , Proteínas de la Membrana/análisis , Proteínas de Neoplasias/análisis , Neoplasias Pancreáticas/química , Células Tumorales Cultivadas/químicaRESUMEN
With physical examination alone it is difficult or even impossible to evaluate the abdominal wall damage in patients with major evisceration, especially when they are obese. Computerized tomography (CT) is very useful in this respect as it provides a detailed anatomical overview of the lesions. CT was performed in 30 out of 229 patients operated upon. It supplied information on the size, site and extension of eviscerations and showed whether they were single or multiple; it also informed on the quality, thickness and retraction of the abdominal muscles. All this is extremely important to know before surgery as it enables the operative problems to be foreseen and, to some extent, the operative procedure to be determined. In all cases of complex evisceration CT may be regarded as the "key examination".
Asunto(s)
Hernia Ventral/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Hernia Ventral/cirugía , HumanosRESUMEN
Iodized oil (lipiodol) injected into the hepatic artery is selectively retained by hepatocarcinomas, as demonstrated by computerized tomography (CT) performed one week after the injection. The value of this technique for the diagnosis of hepatocarcinoma was assessed in a retrospective study of 45 patients. In 39 per cent of the cases intrahepatic tumoral extension was determined by the iodized oil which showed tumoral nodules that had not been detected by conventional methods, such as ultrasonography and CT alone. The lesions revealed by the iodized oil were small nodules around the main tumour. The combined iodized oil-CT technique plays an important role in the choice of treatment, especially when surgical excision is contemplated. It might also contribute to an early diagnosis of hepatocarcinoma in patients at risk, as illustrated by four of our cases where conventional morphological examinations had been negative.
Asunto(s)
Carcinoma Hepatocelular/diagnóstico por imagen , Aceite Yodado/administración & dosificación , Neoplasias Hepáticas/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Anciano , Femenino , Arteria Hepática , Humanos , Masculino , Persona de Mediana EdadRESUMEN
A liquid chromatographic (LC) method is described for determination of the coumarins esculin, umbelliferone, scopoletin, and 4-methyl umbelliferone in hydroalcoholic extracts of oak wood and in matured distilled alcoholic beverages. Samples were injected directly into the LC column (30 cm, 5 micron C18) and detected by fluorescence detector. Under these experimental conditions, only scopoletin (detection limit, 200 pg) was found in hydroalcoholic oak wood extracts and in spirits matured in oak wood. Applications of this method to spirits distilled from wine, grain, and sugar cane aged in oak barrels showed that amounts varied from 0.026 to 1.57 ppm.